Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bromocriptine"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 388
Tytuł:
A giant invasive macroprolactinoma with recurrent nasal bleeding as the first clinical presentation: case report and review of literature.
Autorzy:
Li D; Division of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.; Department of Health Management, Health Management Center, General Practice Center, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.
Wang Y; Division of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.
Tan H; Division of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China. .
Luo P; Division of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.
Yu Y; Division of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, P.R. China.
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2023 May 12; Vol. 23 (1), pp. 107. Date of Electronic Publication: 2023 May 12.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Prolactinoma*/diagnosis
Prolactinoma*/diagnostic imaging
Pituitary Neoplasms*/diagnosis
Pituitary Neoplasms*/diagnostic imaging
Male ; Humans ; Young Adult ; Adult ; Epistaxis/complications ; Epistaxis/drug therapy ; Prolactin ; Bromocriptine/therapeutic use ; Magnetic Resonance Imaging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rapid and dramatic glucose-lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma.
Autorzy:
Igata M; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yagi Y; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Hanatani S; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Sakaguchi M; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Ishii N; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yoshinaga K; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Kawashima J; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Motoshima H; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Araki E; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2021 Apr; Vol. 12 (4), pp. 668-671. Date of Electronic Publication: 2020 Aug 25.
Typ publikacji:
Case Reports
MeSH Terms:
Blood Glucose/*drug effects
Bromocriptine/*therapeutic use
Diabetes Mellitus, Type 2/*drug therapy
Dopamine Agonists/*therapeutic use
Prolactinoma/*drug therapy
Bromocriptine/pharmacology ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Dopamine Agonists/pharmacology ; Female ; Humans ; Middle Aged ; Prolactinoma/complications
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas.
Autorzy:
Wang S; Central lab, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, 241 Pengliuyang Road, Wuchang District, Wuhan, 430060, Hubei, China.; Department of Pharmacy, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, Wuhan, 430060, Hubei, China.; College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, Hubei, China.
Wang A; Health Examination Center, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, 241 Pengliuyang Road, Wuchang District, Wuhan, 430060, Hubei, China.
Zhang Y; Central lab, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, 241 Pengliuyang Road, Wuchang District, Wuhan, 430060, Hubei, China.; Department of Pharmacy, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, Wuhan, 430060, Hubei, China.; College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, Hubei, China.
Zhu K; Central lab, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, 241 Pengliuyang Road, Wuchang District, Wuhan, 430060, Hubei, China.; Department of Pharmacy, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, Wuhan, 430060, Hubei, China.; College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, Hubei, China.
Wang X; Central lab, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, 241 Pengliuyang Road, Wuchang District, Wuhan, 430060, Hubei, China.; Department of Pharmacy, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, Wuhan, 430060, Hubei, China.
Chen Y; Department of Pharmacy, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, Wuhan, 430060, Hubei, China.
Wu J; Central lab, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, 241 Pengliuyang Road, Wuchang District, Wuhan, 430060, Hubei, China. .; Department of Pharmacy, Tongren Hospital Affiliated to Wuhan University, The Third Hospital of Wuhan, Wuhan, 430060, Hubei, China. .
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2021 Nov 23; Vol. 21 (1), pp. 235. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Dopamine Agonists/*therapeutic use
Pituitary Neoplasms/*drug therapy
Pituitary Neoplasms/*enzymology
Prolactinoma/*drug therapy
Prolactinoma/*enzymology
p38 Mitogen-Activated Protein Kinases/*physiology
Animals ; Apoptosis ; Bromocriptine/therapeutic use ; Cell Line, Tumor ; Disease Models, Animal ; Drug Resistance ; Estradiol/administration & dosage ; Estradiol/analogs & derivatives ; Female ; Gene Expression Regulation/drug effects ; Mitogen-Activated Protein Kinase 11/genetics ; Mitogen-Activated Protein Kinase 12/genetics ; Mitogen-Activated Protein Kinase 13/genetics ; Mitogen-Activated Protein Kinase 14/genetics ; Prolactin/genetics ; Prolactinoma/chemically induced ; Rats ; Rats, Sprague-Dawley ; Receptors, Dopamine D1/genetics ; Signal Transduction/physiology ; p38 Mitogen-Activated Protein Kinases/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis.
Autorzy:
Zou Y; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Li D; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Gu J; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Chen S; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Wen X; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Dong J; Jiangmen Central Hospital, Affiliated Jiangmen hospital of Sun Yat-Sen University, Jiangmen, 519000, China. .
Jiang X; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China. .; Jiangmen Central Hospital, Affiliated Jiangmen hospital of Sun Yat-Sen University, Jiangmen, 519000, China. .
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2021 Nov 13; Vol. 21 (1), pp. 225. Date of Electronic Publication: 2021 Nov 13.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Deprescriptions*
Dopamine Agonists/*therapeutic use
Neoplasm Recurrence, Local/*epidemiology
Pituitary Neoplasms/*drug therapy
Prolactinoma/*drug therapy
Bromocriptine/therapeutic use ; Cabergoline/therapeutic use ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review.
Autorzy:
Dai C; Department of Neurosurgery, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Sun B; Department of Neurosurgery, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Guan S; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100730, China.
Wang W; Department of Neurosurgery, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Liu H; Department of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Li Y; Department of Neurosurgery, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Zhang J; Department of Neurosurgery, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Kang J; Department of Neurosurgery, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China. .
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2021 Oct 29; Vol. 21 (1), pp. 217. Date of Electronic Publication: 2021 Oct 29.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Carcinoma/*therapy
Hormone Antagonists/*therapeutic use
Neoplasm Recurrence, Local/*therapy
Pituitary Neoplasms/*therapy
Prolactinoma/*therapy
Spinal Cord Neoplasms/*therapy
Adult ; Bromocriptine/therapeutic use ; Carcinoma/secondary ; Craniotomy ; Disease Progression ; Female ; Humans ; Neurosurgical Procedures ; Pituitary Neoplasms/pathology ; Prolactinoma/pathology ; Radiosurgery ; Reoperation ; Spinal Cord Neoplasms/secondary
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma.
Autorzy:
Košec A; Department of Otorhinolaryngology and Head and Neck Surgery, Zagreb School of Medicine, University Hospital Centre 'Sestre Milosrdnice,' Croatia.
Kruljac I; Department of Endocrinology, Diabetes and Metabolic Diseases 'Mladen Sekso,' University Hospital Centre 'Sestre Milosrdnice,' Zagreb, Croatia.
Ajduk J; Department of Otorhinolaryngology and Head and Neck Surgery, Zagreb School of Medicine, University Hospital Centre 'Sestre Milosrdnice,' Croatia.
Pokaż więcej
Źródło:
American journal of audiology [Am J Audiol] 2019 Sep 13; Vol. 28 (3), pp. 548-552. Date of Electronic Publication: 2019 Aug 20.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Bromocriptine/*therapeutic use
Cochlear Diseases/*drug therapy
Hearing Loss, Sensorineural/*drug therapy
Hormone Antagonists/*therapeutic use
Pituitary Neoplasms/*drug therapy
Prolactinoma/*drug therapy
Adult ; Audiometry, Pure-Tone ; Cochlear Diseases/complications ; Diuretics/therapeutic use ; Furosemide/therapeutic use ; Glucocorticoids/therapeutic use ; Hearing Loss, Sensorineural/complications ; Humans ; Magnetic Resonance Imaging ; Male ; Methylprednisolone/therapeutic use ; Pituitary Neoplasms/complications ; Pituitary Neoplasms/diagnostic imaging ; Pituitary Neoplasms/pathology ; Prolactinoma/complications ; Prolactinoma/diagnostic imaging ; Prolactinoma/pathology ; Recurrence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Sjögren's Syndrome Accompanied by Prolactinoma: a case report and literature review.
Autorzy:
Oh YJ; Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School of Chonbuk National Unversity, Jeonju, Korea.
Lee WS; Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School of Chonbuk National Unversity, Jeonju, Korea.
Yoo WH; Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School of Chonbuk National Unversity, Jeonju, Korea.
Hahm JR; Divison of Endocrinology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.
Kim HO; Divison of Rheumatology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.
Suh YS; Divison of Rheumatology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.
Lee SI; Divison of Rheumatology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.
Cheon YH; Divison of Rheumatology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.
Pokaż więcej
Źródło:
International journal of rheumatic diseases [Int J Rheum Dis] 2017 Nov; Vol. 20 (11), pp. 1823-1826. Date of Electronic Publication: 2015 Sep 10.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Pituitary Neoplasms/*etiology
Prolactinoma/*etiology
Sjogren's Syndrome/*complications
Antineoplastic Agents, Hormonal/therapeutic use ; Biomarkers, Tumor/blood ; Bromocriptine/therapeutic use ; Dopamine Agonists/therapeutic use ; Female ; Humans ; Magnetic Resonance Imaging ; Pituitary Neoplasms/blood ; Pituitary Neoplasms/diagnostic imaging ; Pituitary Neoplasms/drug therapy ; Prolactin/blood ; Prolactinoma/blood ; Prolactinoma/diagnostic imaging ; Prolactinoma/drug therapy ; Sjogren's Syndrome/blood ; Sjogren's Syndrome/diagnosis ; Sjogren's Syndrome/drug therapy ; Treatment Outcome ; Young Adult
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells.
Autorzy:
Huang J; Department of Neurosurgery, Shanghai Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Zhang F; Department of Neurosurgery, The 411th Hospital of PLA, Shanghai, China.
Jiang L; Department of Neurosurgery, Shanghai Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Hu G; Department of Neurosurgery, Shanghai Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Sun W; Department of Neurosurgery, Shanghai Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Zhang C; Department of Neurosurgery, Shanghai Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Ding X; Department of Neurosurgery, Shanghai Institute of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2017 Apr; Vol. 49 (2), pp. 358-373. Date of Electronic Publication: 2016 Jul 28.
Typ publikacji:
Journal Article
MeSH Terms:
Apoptosis/*drug effects
Apoptosis/*genetics
Bromocriptine/*pharmacology
Dopamine Agonists/*pharmacology
Pituitary Neoplasms/*genetics
Prolactinoma/*genetics
S-Phase Kinase-Associated Proteins/*genetics
Adult ; Aged ; Aged, 80 and over ; Cell Line, Tumor ; Female ; Gene Expression ; Gene Knockdown Techniques ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Pituitary Neoplasms/diagnosis ; Pituitary Neoplasms/metabolism ; Prolactin/metabolism ; Prolactinoma/diagnosis ; Prolactinoma/metabolism ; Proteolysis ; S-Phase Kinase-Associated Proteins/antagonists & inhibitors ; S-Phase Kinase-Associated Proteins/metabolism ; Tumor Burden ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism ; Ubiquitination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine.
Autorzy:
Zhang LN; Department of Rheumatology and Clinical Immunology, Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.
Shi TY
Yang YJ
Zhang FC
Pokaż więcej
Źródło:
Lupus [Lupus] 2014 Apr; Vol. 23 (4), pp. 417-20. Date of Electronic Publication: 2014 Jan 20.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Granulomatous Mastitis/*drug therapy
Lupus Erythematosus, Systemic/*complications
Prolactinoma/*drug therapy
Bromocriptine/therapeutic use ; Female ; Granulomatous Mastitis/etiology ; Hormone Antagonists/therapeutic use ; Humans ; Hydroxychloroquine/therapeutic use ; Pituitary Neoplasms/drug therapy ; Pituitary Neoplasms/pathology ; Prednisone/therapeutic use ; Prolactinoma/pathology ; Recurrence ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Medically treated prolactin-secreting pituitary adenomas: when should we operate?
Autorzy:
Vale FL; Department of Neurological Surgery & Brain Repair, University of South Florida, Tampa, FL 33606, USA. />Deukmedjian AR
Hann S
Shah V
Morrison AD
Pokaż więcej
Źródło:
British journal of neurosurgery [Br J Neurosurg] 2013 Feb; Vol. 27 (1), pp. 56-62. Date of Electronic Publication: 2012 Aug 31.
Typ publikacji:
Journal Article
MeSH Terms:
Pituitary Neoplasms/*surgery
Prolactinoma/*surgery
Adult ; Antineoplastic Agents/therapeutic use ; Bromocriptine/therapeutic use ; Cabergoline ; Ergolines/therapeutic use ; Female ; Hormone Antagonists/therapeutic use ; Humans ; Magnetic Resonance Imaging ; Male ; Pituitary Neoplasms/drug therapy ; Postmenopause ; Premenopause ; Prolactinoma/drug therapy ; Prospective Studies ; Retrospective Studies ; Sphenoid Bone/surgery ; Time Factors ; Treatment Failure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child.
Autorzy:
Sakazume S; Department of Paediatrics, Dokkyo University School of Medicine, 2-1-50 Minami-koshigaya, Koshigaya, Saitama, Japan.
Obata K
Takahashi E
Yoshino A
Murakami N
Sakuta R
Murai T
Nagai T
Pokaż więcej
Źródło:
European journal of pediatrics [Eur J Pediatr] 2004 Aug; Vol. 163 (8), pp. 472-4. Date of Electronic Publication: 2004 May 25.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Bromocriptine/*therapeutic use
Dopamine Agonists/*therapeutic use
Growth Disorders/*drug therapy
Hyperprolactinemia/*drug therapy
Pituitary Neoplasms/*drug therapy
Prolactinoma/*drug therapy
Adolescent ; Growth Disorders/etiology ; Humans ; Hyperprolactinemia/complications ; Male ; Pituitary Neoplasms/complications ; Prolactinoma/complications
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study
Autorzy:
Almalki, Mussa H.Aff1, Aff2
Alsuraikh, Moayad A.
Almalki, Eyad
Aziz, Faisal
Almazrouei, RayaAff5, Aff6
AlDahmani, Khaled MAff5, Aff6
Alshahrani, FahadAff7, Aff8
Alaqeel, MeshalAff7, Aff8, Aff9
Mahzari, MoeberAff7, Aff8, Aff10, IDs11102024013832_cor9
Ekhzaimy, Aishah
Pokaż więcej
Źródło:
Pituitary: The official publication of the Pituitary Society and the Growth Hormone Research Society. 27(2):197-203
Czasopismo naukowe
Szczegóły
Tytuł:
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center
Autorzy:
Prencipe, Nunzia
Bona, Chiara
Cuboni, DanielaAff1, IDs11102024013841_cor3
Berton, Alessandro Maria
Bioletto, Fabio
Varaldo, Emanuele
Aversa, Luigi Simone
Sibilla, Michela
Gasco, Valentina
Ghigo, Ezio
Grottoli, Silvia
Pokaż więcej
Źródło:
Pituitary: The official publication of the Pituitary Society and the Growth Hormone Research Society. :1-8
Czasopismo naukowe
Szczegóły
Tytuł:
Network Pharmacology to Explore the Mechanism of Prunella vulgaris L. Against Prolactinoma.
Autorzy:
Meng, Jun-Hua
Ni, Ping
Cao, Yu-Ling
Zhang, Yu
Wang, Xiong
Zhang, Hong
Chen, Yong-Gang
Pokaż więcej
Temat:
PROLACTINOMA
MITOGEN-activated protein kinases
PITUITARY tumors
BROMOCRIPTINE
PHARMACOLOGY
ESTROGEN receptors
WESTERN immunoblotting
Źródło:
Pharmacognosy Magazine; Mar2024, Vol. 20 Issue 1, p127-136, 10p
Terminy geograficzne:
CHINA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Macroprolactinoma with secondary resistance to dopamine agonists: a case report and review of the literature.
Autorzy:
Tng EL; Department of Medicine, Ng Teng Fong General Hospital, 1 Jurong East Street 21, Tower A Level 8, Singapore, 609606, Singapore. .
Teo AE; Department of Medicine, Division of Endocrinology, National University Health System, 1E Kent Ridge Road, NUHS Tower Block Level 10, Singapore, 119228, Singapore.
Aung AT; Ministry of Health Holdings, 1 Maritime Square, #11-25 HarbourFront Centre, Singapore, 099253, Singapore.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Mar 17; Vol. 17 (1), pp. 96. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Prolactinoma*
Pituitary Neoplasms*/pathology
Male ; Humans ; Middle Aged ; Dopamine Agonists/therapeutic use ; Cabergoline/therapeutic use ; Ergolines/therapeutic use ; Prolactin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
How to manage intolerance to dopamine agonist in patients with prolactinoma
Autorzy:
Stumpf, Matheo Augusto MorandiAff1, IDs11102023013138_cor1
Pinheiro, Felipe Moura Maia
Silva, Gilberto Ochman
Cescato, Valter Angelo Sperling
Musolino, Nina Rosa Castro
Cunha-Neto, Malebranche Berardo Carneiro
Glezer, Andrea
Pokaż więcej
Źródło:
Pituitary: The official publication of the Pituitary Society and the Growth Hormone Research Society. :1-10
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 388

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies